SCHEMBL21147010

SCHEMBL21147010

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5ccc6oc7ccccc7c6c5)c4)nc(-n4c5ccccc5c5cccc(-c6ccccc6)c54)n3)cc2-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.35
PLA2G4A P47712 4/20 0.35
PLA2G10 O15496 1/20 0.35
CHEK2 O96017 1/20 0.34
PRKDC P78527 1/20 0.32
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
RAB9A P51151 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
DUSP3 P51452 1/20 0.30
ALOX5 P09917 1/20 0.30
PIM1 P11309 1/20 0.30
CSNK2A2 P19784 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21147553 0.98 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL21146964 0.96 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL21147550 0.96 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL21147565 0.96 CHEK2 (0.34) PLA2G2APLA2G4APLA2G10CHEK2HSP90AA1
SCHEMBL21147552 0.91 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL21147549 0.91 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL25802733 0.91 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL21147299 0.91 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL21147551 0.91 PLA2G2A (0.33) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL21146961 0.91 PLA2G2A (0.33) PLA2G2APLA2G4APLA2G10CHEK2PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
US-20200212314-A1 ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 US disclosed
US-20190214570-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CRY1, CYP1B1, CYP1A1 PLA2G2A 4266/4885PLA2G4A 4371/4885PLA2G10 4214/4885
US-20190214570-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND CRY1, CYP1B1, CYP1A1 PLA2G2A 4266/4885PLA2G4A 4371/4885PLA2G10 4214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.